Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging

A. Gatto, A. M. De Gaetano, M. Giuga, M. Ciresa, L. Siciliani, L. Miele, L. Riccardi, F. Pizzolante, G. L. Rapaccini, A. Gasbarrini, F. Giuliante, F. M. Vecchio, M. Pompili, L. Bonomo

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose: We evaluated whether the addition of delayed phase imaging (DPI) gadobenate dimeglumine-enhanced MRI to dynamic postcontrast imaging improves the characterization of small hepatocellular carcinoma (HCC) and the differentiation between HCC, high grade dysplastic nodules (HGDN), and low grade dysplastic nodules (LGDN). Methods: Twenty-five cirrhotic patients with 30 nodules (16 HCC, 8 HGDNs, and 6 LGDNs; maximum size of 3 cm) were included in this retrospective study. The diagnostic reference standard was histology. All the patients underwent MRI both prior to and following intravenous administration of gadobenate dimeglumine. The lesions were classified as hypointense, isointense, hyperintense on DPI for qualitative assessment. In the quantitative analysis the relative tumor-liver contrast to noise ratio (CNR) of the lesions on DPI was calculated. Results: All HCCs were hypointense on DPI while only 8 (57.1%) of 14 DNs were hypointense and only 1 of 6 (16.6%) LGDNs was hypointense. There was a statistically significant difference in the hypointensity on DPI between HCCs and DNs (p = 0.003) in the qualitative analysis but not in the CNR values while there was a strong statistically significant difference in the hypointensity on DPI in the qualitative (p = 0.00001) and quantitative analysis (p <0.05) between LGDNs and the group obtained by unifying HGDNs and HCCs. Conclusion: DPI is helpful in differentiating HCCs and HGDNs from LGDNs. Demonstration of hypointensity on DPI should raise the suspicion of HGDN or hypovascular HCC in the case of nodules with atypical dynamic pattern.

Original languageEnglish
Pages (from-to)736-744
Number of pages9
JournalAbdominal Imaging
Volume38
Issue number4
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Hepatocellular Carcinoma
Magnetic Resonance Imaging
Noise
Intravenous Administration
Histology
Retrospective Studies
gadobenic acid
Liver
Neoplasms

Keywords

  • Dysplastic nodule
  • Hepatobiliary contrast agent
  • Hepatocellular carcinoma
  • Liver cirrhosis
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Gastroenterology
  • Urology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging. / Gatto, A.; De Gaetano, A. M.; Giuga, M.; Ciresa, M.; Siciliani, L.; Miele, L.; Riccardi, L.; Pizzolante, F.; Rapaccini, G. L.; Gasbarrini, A.; Giuliante, F.; Vecchio, F. M.; Pompili, M.; Bonomo, L.

In: Abdominal Imaging, Vol. 38, No. 4, 08.2013, p. 736-744.

Research output: Contribution to journalArticle

Gatto, A, De Gaetano, AM, Giuga, M, Ciresa, M, Siciliani, L, Miele, L, Riccardi, L, Pizzolante, F, Rapaccini, GL, Gasbarrini, A, Giuliante, F, Vecchio, FM, Pompili, M & Bonomo, L 2013, 'Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging', Abdominal Imaging, vol. 38, no. 4, pp. 736-744. https://doi.org/10.1007/s00261-012-9950-y
Gatto, A. ; De Gaetano, A. M. ; Giuga, M. ; Ciresa, M. ; Siciliani, L. ; Miele, L. ; Riccardi, L. ; Pizzolante, F. ; Rapaccini, G. L. ; Gasbarrini, A. ; Giuliante, F. ; Vecchio, F. M. ; Pompili, M. ; Bonomo, L. / Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging. In: Abdominal Imaging. 2013 ; Vol. 38, No. 4. pp. 736-744.
@article{7c199c16be7941d1a9c0b5b3f00f51ce,
title = "Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging",
abstract = "Purpose: We evaluated whether the addition of delayed phase imaging (DPI) gadobenate dimeglumine-enhanced MRI to dynamic postcontrast imaging improves the characterization of small hepatocellular carcinoma (HCC) and the differentiation between HCC, high grade dysplastic nodules (HGDN), and low grade dysplastic nodules (LGDN). Methods: Twenty-five cirrhotic patients with 30 nodules (16 HCC, 8 HGDNs, and 6 LGDNs; maximum size of 3 cm) were included in this retrospective study. The diagnostic reference standard was histology. All the patients underwent MRI both prior to and following intravenous administration of gadobenate dimeglumine. The lesions were classified as hypointense, isointense, hyperintense on DPI for qualitative assessment. In the quantitative analysis the relative tumor-liver contrast to noise ratio (CNR) of the lesions on DPI was calculated. Results: All HCCs were hypointense on DPI while only 8 (57.1{\%}) of 14 DNs were hypointense and only 1 of 6 (16.6{\%}) LGDNs was hypointense. There was a statistically significant difference in the hypointensity on DPI between HCCs and DNs (p = 0.003) in the qualitative analysis but not in the CNR values while there was a strong statistically significant difference in the hypointensity on DPI in the qualitative (p = 0.00001) and quantitative analysis (p <0.05) between LGDNs and the group obtained by unifying HGDNs and HCCs. Conclusion: DPI is helpful in differentiating HCCs and HGDNs from LGDNs. Demonstration of hypointensity on DPI should raise the suspicion of HGDN or hypovascular HCC in the case of nodules with atypical dynamic pattern.",
keywords = "Dysplastic nodule, Hepatobiliary contrast agent, Hepatocellular carcinoma, Liver cirrhosis, Magnetic resonance imaging",
author = "A. Gatto and {De Gaetano}, {A. M.} and M. Giuga and M. Ciresa and L. Siciliani and L. Miele and L. Riccardi and F. Pizzolante and Rapaccini, {G. L.} and A. Gasbarrini and F. Giuliante and Vecchio, {F. M.} and M. Pompili and L. Bonomo",
year = "2013",
month = "8",
doi = "10.1007/s00261-012-9950-y",
language = "English",
volume = "38",
pages = "736--744",
journal = "Abdominal Imaging",
issn = "0942-8925",
number = "4",

}

TY - JOUR

T1 - Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging

AU - Gatto, A.

AU - De Gaetano, A. M.

AU - Giuga, M.

AU - Ciresa, M.

AU - Siciliani, L.

AU - Miele, L.

AU - Riccardi, L.

AU - Pizzolante, F.

AU - Rapaccini, G. L.

AU - Gasbarrini, A.

AU - Giuliante, F.

AU - Vecchio, F. M.

AU - Pompili, M.

AU - Bonomo, L.

PY - 2013/8

Y1 - 2013/8

N2 - Purpose: We evaluated whether the addition of delayed phase imaging (DPI) gadobenate dimeglumine-enhanced MRI to dynamic postcontrast imaging improves the characterization of small hepatocellular carcinoma (HCC) and the differentiation between HCC, high grade dysplastic nodules (HGDN), and low grade dysplastic nodules (LGDN). Methods: Twenty-five cirrhotic patients with 30 nodules (16 HCC, 8 HGDNs, and 6 LGDNs; maximum size of 3 cm) were included in this retrospective study. The diagnostic reference standard was histology. All the patients underwent MRI both prior to and following intravenous administration of gadobenate dimeglumine. The lesions were classified as hypointense, isointense, hyperintense on DPI for qualitative assessment. In the quantitative analysis the relative tumor-liver contrast to noise ratio (CNR) of the lesions on DPI was calculated. Results: All HCCs were hypointense on DPI while only 8 (57.1%) of 14 DNs were hypointense and only 1 of 6 (16.6%) LGDNs was hypointense. There was a statistically significant difference in the hypointensity on DPI between HCCs and DNs (p = 0.003) in the qualitative analysis but not in the CNR values while there was a strong statistically significant difference in the hypointensity on DPI in the qualitative (p = 0.00001) and quantitative analysis (p <0.05) between LGDNs and the group obtained by unifying HGDNs and HCCs. Conclusion: DPI is helpful in differentiating HCCs and HGDNs from LGDNs. Demonstration of hypointensity on DPI should raise the suspicion of HGDN or hypovascular HCC in the case of nodules with atypical dynamic pattern.

AB - Purpose: We evaluated whether the addition of delayed phase imaging (DPI) gadobenate dimeglumine-enhanced MRI to dynamic postcontrast imaging improves the characterization of small hepatocellular carcinoma (HCC) and the differentiation between HCC, high grade dysplastic nodules (HGDN), and low grade dysplastic nodules (LGDN). Methods: Twenty-five cirrhotic patients with 30 nodules (16 HCC, 8 HGDNs, and 6 LGDNs; maximum size of 3 cm) were included in this retrospective study. The diagnostic reference standard was histology. All the patients underwent MRI both prior to and following intravenous administration of gadobenate dimeglumine. The lesions were classified as hypointense, isointense, hyperintense on DPI for qualitative assessment. In the quantitative analysis the relative tumor-liver contrast to noise ratio (CNR) of the lesions on DPI was calculated. Results: All HCCs were hypointense on DPI while only 8 (57.1%) of 14 DNs were hypointense and only 1 of 6 (16.6%) LGDNs was hypointense. There was a statistically significant difference in the hypointensity on DPI between HCCs and DNs (p = 0.003) in the qualitative analysis but not in the CNR values while there was a strong statistically significant difference in the hypointensity on DPI in the qualitative (p = 0.00001) and quantitative analysis (p <0.05) between LGDNs and the group obtained by unifying HGDNs and HCCs. Conclusion: DPI is helpful in differentiating HCCs and HGDNs from LGDNs. Demonstration of hypointensity on DPI should raise the suspicion of HGDN or hypovascular HCC in the case of nodules with atypical dynamic pattern.

KW - Dysplastic nodule

KW - Hepatobiliary contrast agent

KW - Hepatocellular carcinoma

KW - Liver cirrhosis

KW - Magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=84882272103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882272103&partnerID=8YFLogxK

U2 - 10.1007/s00261-012-9950-y

DO - 10.1007/s00261-012-9950-y

M3 - Article

VL - 38

SP - 736

EP - 744

JO - Abdominal Imaging

JF - Abdominal Imaging

SN - 0942-8925

IS - 4

ER -